matthew galsky, md, discusses the practice-changing potential of the profound study from esmo 2020
Published 3 years ago • 27 plays • Length 2:30
Download video MP4
Download video MP3
Similar videos
-
2:21
eleni efstathiou, md, phd, on the practice-changing potential of the profound study from esmo 2020
-
2:09
matthew galsky, md, regarding the trophy-u-01 study presented at the 2020 esmo virtual congress
-
1:04
matthew galsky, md, on how studies focused on genetic mutations impact prostate cancer treatment
-
1:58
matthew galsky, md, considers the implications of the imvigor130 clinical study
-
44:28
breakthroughs in bladder cancer immunotherapy, with matthew galsky
-
2:36
matthew galsky, md, on the checkmate-274 study in high risk, muscle-invasive urothelial carcinoma
-
1:10
matthew galsky, md, tells us about the phase 3 imvigor130 study in advanced urothelial cancer
-
2:01
matthew galsky, md, tells us about the design and outcomes of the ev-301 trial from asco gu '21
-
26:20
management of non-muscle invasive bladder cancer
-
1:27:30
eat to beat prostate disease
-
3:24
'tumors just vanished': cancer patients now in remission after drug trial
-
3:31
matthew galsky, md, on the role of pd-l1 testing in previously untreated, locally advanced or muc
-
1:08
matthew galsky, md, shares a message for patients regarding clinical progress in bladder cancer
-
6:53
psmafore: methodology, nuances, and implications
-
2:12
matthew galsky, md, shares the design and outcomes of the javelin bladder 100 study
-
22:31
targeted therapy: recent advances in prostate cancer from esmo 2019
-
2:52
esmo dr. galsky
-
32:24
developing and translating novel immunotherapies for prostate cancer - christina jamieson
-
48:37
breakthroughs in prostate and bladder cancer treatment - full video
-
1:43
matthew galsky on treating different subsets of bladder cancer
-
1:36
dr. galsky discusses neoadjuvant immunotherapy in bladder cancer
-
8:41
ev-302 and checkmate 901: comparing the practice-changing esmo data for metastatic uc
Clip.africa.com - Privacy-policy